Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Incidence, Risk Factors, and Outcomes of BK Hemorrhagic Cystitis in Hematopoietic Stem Cell Transplantation From HLA-Matched and Haploidentical Donors With Post-Transplant Cyclophosphamide.
Chorão P, Villalba M, Balaguer-Roselló A, Montoro J, Granados P, Gilabert C, Panadero F, Pardal AA, González EM, de Cossio S, Benavente R, Gómez MD, Gómez I, Solves P, Santiago M, Asensi P, Lloret P, Eiris J, Martínez D, Louro A, Rebollar P, Perla A, Salavert M, Rubia J, Sanz MÁ, Sanz J. Chorão P, et al. Transplant Cell Ther. 2024 Dec 17:S2666-6367(24)00809-1. doi: 10.1016/j.jtct.2024.12.006. Online ahead of print. Transplant Cell Ther. 2024. PMID: 39701290
Gastric Bleeding in Stem Cell Transplantation: A Focus on Gastric Vascular Ectasia Under Post-Transplant Cyclophosphamide, Sirolimus, and Mycophenolate Mofetil Prophylaxis.
Eirís J, Montoro J, Villalba M, Chorão P, Pérez-Bravo M, Rausell N, Satorres C, Asensi Cantó P, Gómez-Seguí I, Solves P, Santiago M, Lloret-Madrid P, Granados P, Martínez-Campuzano D, Benavente R, Louro A, Rebollar P, Perla A, Sanz MA, de la Rubia J, Balaguer-Roselló A, Sanz J. Eirís J, et al. Among authors: chorao p. Transplant Cell Ther. 2024 Oct 17:S2666-6367(24)00726-7. doi: 10.1016/j.jtct.2024.10.009. Online ahead of print. Transplant Cell Ther. 2024. PMID: 39424278
Incidence, risk factors and therapy response of acute graft-versus-host disease after myeloablative hematopoietic stem cell transplantation with posttransplant cyclophosphamide.
Asensi Cantó P, Gómez-Seguí I, Montoro J, Villalba Montaner M, Chorão P, Solves Alcaína P, Santiago Balsera M, Lloret Madrid P, Solís Ruiz J, Sopeña Pell-Ilderton C, Martínez Campuzano D, Granados Serrano P, Eiris Del Río J, Louro A, Rebollar P, Perla A, Benavente R, De la Rubia Comos J, Sanz MA, Balaguer A, Sanz J. Asensi Cantó P, et al. Among authors: chorao p. Bone Marrow Transplant. 2024 Nov;59(11):1577-1584. doi: 10.1038/s41409-024-02391-3. Epub 2024 Aug 24. Bone Marrow Transplant. 2024. PMID: 39181954
Comparison of Three Graft-versus-Host Disease Prophylaxis Strategies after T Cell-Replete Haploidentical Hematopoietic Transplantation: Tacrolimus versus Calcineurin Inhibitors + Mycophenolate Mofetil versus Sirolimus + Mycophenolate Mofetil.
Esquirol A, Pascual MJ, Montoro J, Piñana JL, Ferrà C, Herruzo B, Garcia-Cadenas I, Balaguer A, Perez A, Huguet M, Redondo S, Villalba M, Hernandez-Boluda JC, Chorao P, Hernani R, Sanz J, Solano C, Sierra J, Martino R. Esquirol A, et al. Among authors: chorao p. Transplant Cell Ther. 2024 Oct;30(10):1025.e1-1025.e14. doi: 10.1016/j.jtct.2024.07.027. Epub 2024 Aug 6. Transplant Cell Ther. 2024. PMID: 39116938
Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy.
Piñana JL, Vazquez L, Heras I, Aiello TF, López-Corral L, Arroyo I, Soler-Espejo E, García-Cadenas I, Garcia-Gutierrez V, Aroca C, Chorao P, Olave MT, Lopez-Jimenez J, Gómez MA, Arellano E, Cuesta-Casas M, Avendaño-Pita A, González-Santillana C, Hernández-Rivas JÁ, Roldán-Pérez A, Mico-Cerdá M, Guerreiro M, Morell J, Rodriguez-Galvez P, Labrador J, Campos D, Cedillo Á, Vidal CG, Martino R, Solano C. Piñana JL, et al. Among authors: chorao p. Front Oncol. 2024 Jun 19;14:1389345. doi: 10.3389/fonc.2024.1389345. eCollection 2024. Front Oncol. 2024. PMID: 39015498 Free PMC article.
Longitudinal outcome over four decades of allogeneic stem cell transplantation: a single center experience.
Sanz MÁ, Montoro J, Balaguer-Roselló A, Chorão P, Villalba M, Gómez I, Solves P, Santiago M, Asensi P, Lamas B, Bataller A, Granados P, Eiris J, Martinez D, Lloret P, Louro A, Rebollar P, Perla A, de la Rubia J, Sanz J. Sanz MÁ, et al. Among authors: chorao p. Bone Marrow Transplant. 2024 Oct;59(10):1376-1386. doi: 10.1038/s41409-024-02319-x. Epub 2024 Jun 25. Bone Marrow Transplant. 2024. PMID: 38918495
Total body irradiation versus thiotepa/busulfan-based conditioning regimens for myeloablative allogeneic stem cell transplantation in adults with acute lymphoblastic leukemia.
Mora E, Montoro J, Balaguer A, Rovira M, Cabrero M, Heras I, Ribera JM, Antelo G, Martin AA, Lopez Godino O, Torrent A, Villalba M, Chorao P, Sanz MA, Sanz J; Grupo Español de Trasplante Hematopoyético (GETH). Mora E, et al. Among authors: chorao p. Bone Marrow Transplant. 2024 Aug;59(8):1137-1145. doi: 10.1038/s41409-024-02298-z. Epub 2024 May 16. Bone Marrow Transplant. 2024. PMID: 38755458
Are any specific respiratory viruses more severe than others in recipients of allogeneic stem cell transplantation? A focus on lower respiratory tract disease.
Pérez A, Gómez D, Montoro J, Chorão P, Hernani R, Guerreiro M, Villalba M, Albert E, Carbonell-Asins JA, Hernández-Boluda JC, Navarro D, Solano C, Piñana JL. Pérez A, et al. Among authors: chorao p. Bone Marrow Transplant. 2024 Aug;59(8):1118-1126. doi: 10.1038/s41409-024-02304-4. Epub 2024 May 10. Bone Marrow Transplant. 2024. PMID: 38730040
29 results